Galectin-3 and soluble RAGE as new biomarkers of post-infarction cardiac remodeling

J Mol Med (Berl). 2021 Jul;99(7):943-953. doi: 10.1007/s00109-021-02054-6. Epub 2021 Feb 27.

Abstract

Post-infarction remodeling is a clinical problem with no curative treatment. Our objective was to search for new biomarkers of cardiac remodeling that have clinical value after ST-segment elevation myocardial infarction (STEMI). This pilot study enrolled 67 consecutive patients with de novo STEMI who underwent revascularization by primary angioplasty. Echocardiography studies of cardiac function were completed during the first 48 h post-STEMI and after 6 months of follow-up. Galectin-3 and soluble receptor for advanced glycation end products (sRAGE) were tested in the peripheral venous blood during the 24 h post-infarction. Cardiac remodeling was defined as changes ≥ 15% in the left ventricular end-systolic volume (LVESV) or > 10% in the left atrial area (LAA). An inverse association was found between galectin-3 (rs = - 0.296; p < 0.001) and sRAGE (rs = - 0.327; p < 0.001) levels and the basal left ventricle ejection fraction (LVEF). However, only galectin-3 was directly associated with the increase in LVESV (rs = 0.389; p = 0.007) and LVEDV (rs = 0.314; p = 0.031) during the follow-up. sRAGE was inversely related to the change in LAA (rs = - 0.320; p = 0.032). These data are consistent with galectin-3, but not sRAGE levels, as a predictor of left ventricle remodeling (OR 1.036, 95% CI 1.002-1.071; p = 0.039). Galectin-3 and sRAGE levels that were measured during hospitalization are inversely related to basal LVEF after a STEMI. Galectin-3 levels are a predictor of adverse post-STEMI LV remodeling, whereas sRAGE levels exhibited an inverse relationship with left atrial remodeling. KEY MESSAGES: Post-infarction remodeling is a clinical problem with no curative treatment. New biomarkers for remodeling after acute myocardial infarction were explored. Early post-STEMI galectin-3 and soluble RAGE are inversely related with left ventricle function. Galectin-3 levels were predictors of adverse post-STEMI left ventricle remodeling. Soluble RAGE levels were associated with left atrial remodeling.

Keywords: Acute myocardial infarction with ST-segment elevation; Biomarkers; Galectin-3; Post-infarction remodeling; Soluble RAGE.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Atrial Remodeling*
  • Biomarkers / blood
  • Blood Proteins
  • Echocardiography
  • Female
  • Galectins / blood*
  • Humans
  • Male
  • Middle Aged
  • Pilot Projects
  • Receptor for Advanced Glycation End Products / blood*
  • ST Elevation Myocardial Infarction / blood*
  • ST Elevation Myocardial Infarction / diagnostic imaging
  • ST Elevation Myocardial Infarction / physiopathology
  • Ventricular Function, Left
  • Ventricular Remodeling*

Substances

  • AGER protein, human
  • Biomarkers
  • Blood Proteins
  • Galectins
  • LGALS3 protein, human
  • Receptor for Advanced Glycation End Products